Skip to main content

Published locations for Ocrelizumab outperforms fingolimod after natalizumab cessation in RRMS

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. Ocrelizumab outperforms fingolimod after natalizumab cessation in RRMS

User login

  • Reset your password
  • /content/ocrelizumab-outperforms-fingolimod-after-natalizumab-cessation-rrms
  • /neurology/msresourcecenter/article/250895/multiple-sclerosis/ocrelizumab-outperforms-fingolimod